Direct medical costs of non-alcoholic fatty liver disease in Catalonia at the hospital level: a retrospective multicenter study

dc.contributor.authorDarbà, Josep
dc.date.accessioned2022-06-02T12:13:47Z
dc.date.available2023-03-01T06:10:27Z
dc.date.issued2022-03-01
dc.date.updated2022-06-02T12:13:47Z
dc.description.abstractThe prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing worldwide, which is expected to correlate with significant medical and social costs. This study aimed to evaluate the clinical and economic burden of NAFLD in Catalonia at the hospital level.
dc.format.extent9 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec707001
dc.identifier.issn1473-7167
dc.identifier.urihttps://hdl.handle.net/2445/186202
dc.language.isoeng
dc.publisherInforma Healthcare
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1080/14737167.2021.1890586
dc.relation.ispartofExpert Review of Pharmacoeconomics & Outcomes Research, 2022, vol. 22, num. 2, p. 341-349
dc.relation.urihttps://doi.org/10.1080/14737167.2021.1890586
dc.rights(c) Informa Healthcare, 2022
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Economia)
dc.subject.classificationTractament de l'alcoholisme
dc.subject.classificationPolítica sanitària
dc.subject.classificationCost de l'assistència sanitària
dc.subject.otherAlcoholism treatment
dc.subject.otherMedical policy
dc.subject.otherCost of medical care
dc.titleDirect medical costs of non-alcoholic fatty liver disease in Catalonia at the hospital level: a retrospective multicenter study
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
707001.pdf
Mida:
1.13 MB
Format:
Adobe Portable Document Format